Greenwich LifeSciences (GLSI) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Greenwich LifeSciences (GLSI) is Neutral.

The composite score behind that read is -0.18, weighing +0.22 of bullish evidence against -0.42 bearish.

Greenwich LifeSciences last closed at $16.53, +9.18% on the session.

Against the IVW growth benchmark the position is +8.38% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for GLSI so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Greenwich LifeSciences in the 1st percentile on return on equity, where 100 is best.

Greenwich LifeSciences is classified under Health Care / Biotechnology, with a market capitalisation of $222.22M.

StockMap tracks Greenwich LifeSciences as the 238th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Greenwich LifeSciences ranks 300th of 381 in the group, against a group median of -0.08.